Table 2.
Patient baseline characteristics and post-operative stimulation outcomes
| Patient ID |
Age (years) |
Sex | BMI | Pre- Implant TSS (out of 20)† |
Post- Impant TSS (out of 20)† |
Pre-Op 4- hr Gastric Retention (%) |
Post-Op 4-hr Gastric Retention (%) |
|---|---|---|---|---|---|---|---|
| 1 | 30 | M | 27.8 | 13 | No Data | 26.9 | No Data |
| 2 | 39 | M | 27.3 | No Data | 7.5 | 41 | No Data |
| 3 | 32 | M | 21.2 | 14.5 | No Data | 21.5 | No Data |
| 4 | 57 | M | 46.2 | 6 | 0 | 21 | 17 |
| 5 | 30 | M | 20.5 | 17.5 | 13 | 34 | 23 |
| 6 | 50 | F | 31.6 | 18 | 13 | 27 | No Data |
| 7 | 42 | M | 25.3 | 14 | 8.5 | 47 | 42 |
| 8 | 62 | M | 32.5 | 20 | 12 | 25 | 12 |
| Median: | 40.5 | - | 27.6 | 14.5 | 10.3 | 27 | 20 |
†
TSS (‘total symptom score’) is a combined metric for the severity of nausea, vomiting, early-satiety, pain, and bloating [17].
Bold text presents the median values across the cohort